×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: sarm1-inhibitors-neurodegeneration
therapeutic
1,088 words
KG: SARM1
Contents
sarm1-inhibitors-neurodegeneration
💊
Therapeutic Info
Name
SARM1
Key Genes/Proteins
BDNF
,
AXON
Related Diseases
Depressive-Like Behavior
,
Alzheimer's Disease
,
Memory Impairment
Related Pathways
Jnk/Sting/Tbk1 Pathway
Linked Hypotheses
1 hypotheses
Knowledge Graph
Related Hypotheses (30)
SASP-Mediated Complement Cascade Amplification
Score: 0.92
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.88
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.86
Transcriptional Autophagy-Lysosome Coupling
Score: 0.86
CYP46A1 Overexpression Gene Therapy
Score: 0.84
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.81
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.78
Senescence-Activated NAD+ Depletion Rescue
Score: 0.78
Digital Twin-Guided Metabolic Reprogramming
Score: 0.78
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.77
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.77
Multi-Modal Stress Response Harmonization
Score: 0.76
Circadian-Synchronized Proteostasis Enhancement
Score: 0.75
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.75
Competitive APOE4 Domain Stabilization Peptides
Score: 0.75
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.75
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.74
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.74
Smartphone-Detected Motor Variability Correction
Score: 0.73
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.73
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.73
Senescent Cell Mitochondrial DNA Release
Score: 0.72
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.72
Blood-Brain Barrier SPM Shuttle System
Score: 0.72
Adenosine-Astrocyte Metabolic Reset
Score: 0.72
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.72
Circadian Clock-Autophagy Synchronization
Score: 0.72
Microbial Inflammasome Priming Prevention
Score: 0.72
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.71
Retinal Vascular Microcirculation Rescue
Score: 0.71
Show 25 more
Related Analyses (30)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Show 25 more
Related Experiments (30)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40
s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40
Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40
s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40
s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.40
Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40
Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40
s:** - Compare uptake with/without magnetic particles using
falsification · proposed · Score: 0.40
Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.40
s:** - Test tau spreading in AQP4 knockout vs wild-type mice
falsification · proposed · Score: 0.40
Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40
s:** - Compare tau strain spreading in EXT1/EXT2 conditional
falsification · proposed · Score: 0.40
Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.40
Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40
s:** - Dose-response studies showing therapeutic window with
falsification · proposed · Score: 0.40
Proposed experiment from debate on Senolytics targeting p16/
falsification · proposed · Score: 0.40
Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.40
Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40
Blood-Brain Barrier Aging and Neurodegeneration — From Leaka
validation · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr
clinical · proposed · Score: 0.40
DLB Cognitive Fluctuation Mechanism Experiment
clinical · proposed · Score: 0.40
Genetic Risk Modifiers in DLB Phenotype
clinical · proposed · Score: 0.40
Tau Co-Pathology in DLB Clinical Heterogeneity
clinical · proposed · Score: 0.40
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.40
Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40
Show 25 more
See Also (15)
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 139 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 139 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 139 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 139 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 139 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 139 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 139 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 139 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 139 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 139 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 139 hypotheses
Tau Kinase Signaling Cascade in Alzheimer's Disease
mechanism · Pages share 37 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 139 hypotheses
Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 139 hypotheses
synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 139 hypotheses
Show 10 more
Knowledge Graph (12 edges)
SARM1
activates
DLK
SARM1
activates
PUMA
SARM1
activates
Ms
SARM1
activates
Apoptosis
SARM1
activates
Mapk
SARM1
activates
GBM
SARM1
therapeutic_target
GLIOBLASTOMA
SARM1
therapeutic_target
CANCER
SARM1
activates
Tumor
SARM1
therapeutic_target
Glioma